-- 周一,原油价格上涨提振了主要生物燃料原料价格,但出口疲软的迹象限制了马来西亚棕榈油的涨幅。 芝加哥期货交易所(CBOT)5月大豆油合约上涨1.16%,至每磅67.87美分,美国强劲的生物燃料计划为其提供了上涨动力。 然而,大豆供应充足令大豆期货承压,CBOT 5月合约早盘下跌0.11%,至每蒲式耳11.75美元。 南美洲方面,报告显示,截至4月初,巴西大豆收割进度已达82%,而阿根廷的进度仅为2.4%。 美国农业部预计大豆种植面积为8470万英亩,低于预期。 价格报告机构MySteel表示:“市场仍处于南美供应充足与美国种植面积减少和需求改善之间的两难境地。”该机构补充说,因此大豆价格可能将呈区间震荡走势。 在亚洲,马来西亚衍生品交易所5月原棕榈油合约在经历一段波动后收盘上涨0.24%,至每吨4,511马来西亚林吉特(1,134.99美元)。6月合约上涨0.37%,至每吨4,555林吉特。 自2月下旬以来,不断升级的地缘政治冲突推高了棕榈油价格,但出口疲软的迹象令今日的期货价格承压。 马来西亚棕榈油局局长艾哈迈德·帕尔维兹告诉《星报》,由于航运中断导致出口利润率下降,行业利润可能无法完全反映价格飙升。 据报道,帕尔维兹表示,由于绕道非洲的航运路线将运输时间延长了近两周,马来西亚在中东的主要市场也可能转向附近的供应商。 据货运调查机构称,4月前10天,马来西亚的货运量较上月下降了30.7%至38.9%。如果4月份出口持续走低,这一趋势可能会逆转3月份货运量环比增长40.7%的局面。 路透社援引Sunvin集团的阿尼尔库马尔·巴加尼的话说,需要出口表现进一步强劲才能促进本月国内库存下降。 《新海峡时报》援引联昌证券的话说,如果需求持续旺盛且产量下降,马来西亚4月份的库存量可能从3月份的230万吨进一步降至220万吨。 印尼自7月1日起将生物柴油掺混比例从40%提高至50%,此举或将提振该国的出口需求。 另一方面,化肥供应中断和厄尔尼诺现象带来的风险可能导致产量下降。 在美国,纽约商品交易所(NYMEX)5月交割的乙醇期货价格周五上涨0.52%,至每加仑约1.94美元。
Related Articles
Dongjiang Environmental's Loss Widens 2.7% in Q1
Dongjiang Environmental (HKG:0895, SHE:002672) recorded an attributable loss of 150.2 million yuan in the first quarter of 2026, 2.7% wider than 146.3 million yuan a year prior, according to a Monday Hong Kong bourse filing.Loss per share widened to 0.14 yuan from 0.13 yuan in the corresponding period of the previous fiscal year.The waste disposal management company's revenue from operations declined 13% to 602.6 million yuan from 695.9 million yuan in the year-ago period.
Sector Update: Health Care Stocks Edge Higher Pre-Bell Monday
Health care stocks were edging higher pre-bell Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.2% and the iShares Biotechnology ETF (IBB) marginally advancing.Organon (OGN) has agreed to be acquired by Sun Pharmaceutical Industries for $14 per share in an all-cash deal with an $11.75 billion enterprise valuation, the companies said. Shares of Organon were up more than 17% premarket.Oruka Therapeutics (ORKA) stock was up more than 34% after the company said 63.5% of patients treated with ORKA-001 achieved the primary endpoint of complete skin clearance at week 16 in a phase 2a trial in moderate-to-severe plaque psoriasis.Ligand Pharmaceuticals (LGND) shares were up more than 3% after the company said it has agreed to purchase biotechnology peer Xoma Royalty (XOMA) in an all-cash deal valued at roughly $739 million.
Zuoli Kechuang Logs Drop in Q1 Profit
Zuoli Kechuang Micro-finance Company (HKG:6866) recorded a decline in attributable profit in the first quarter of 2026 to 13.6 million yuan from 14.8 million yuan a year prior, according to a Monday Hong Kong bourse filing.Net interest income for the three months slipped to 28.4 million yuan from 35.2 million yuan in the year-ago period.